Tara Dwelley
Family · Princeton, MENPI 1780649137
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $405, 2.2 times the $181 reported in 2021. Among family clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$260
- Novo Nordisk$186
- GSK$162
- Lundbeck LLC$158
- AstraZeneca$121
- Sanofi-aventis U.S. LLC$88
- plus $553 from 17 others
What the payments were for
- Food & beverage$1,51399%
- Other$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 15 | $260 |
| Novo Nordisk | 11 | $186 |
| GSK | 10 | $162 |
| Lundbeck LLC | 7 | $158 |
| AstraZeneca | 7 | $121 |
| Sanofi-aventis U.S. LLC | 7 | $88 |
| Exact Sciences | 3 | $58 |
| Novartis | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Lilly USA, LLC | 3 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $39 |
| Abbott | 2 | $39 |
| Merck | 2 | $36 |
| Boehringer Ingelheim | 2 | $35 |
| Johnson & Johnson | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
How this compares
$1,527 in reported general payments places this provider in the 90th percentile of 545 family providers in Maine.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 81 | $78,398 |
| OzempicSemaglutide | 42 | $46,245 |
| EliquisApixaban | 37 | $43,260 |
| JardianceEmpagliflozin | 26 | $41,840 |
| FarxigaDapagliflozin Propanediol | 33 | $38,597 |
| MounjaroTirzepatide | 17 | $19,046 |
| RybelsusSemaglutide | 14 | $17,547 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $17,032 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $15,428 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 65 | $7,985 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $6,899 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 11 | $4,613 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $4,320 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 168 | $3,793 |
| Pregabalin | 49 | $2,870 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Arnuity Ellipta | $162 | $80,63092 claims |
| Novo NordiskOzempic, Rybelsus | $186 | $63,79256 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere | $121 | $60,24361 claims |
| PfizerEliquis | $260 | $43,26037 claims |
| Boehringer IngelheimJardiance | $35 | $41,84026 claims |
| Lilly USA, LLCMounjaro | $50 | $19,04617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 545 family providers in Maine.
Other family in Princeton
- Michael SwopePrinceton$2K
- Phylicia BonavidaPrinceton$2K
- Mia RapollaFalmouth$193K
- Patti DupreyKennebunk$35K
- Amanda WilliamsPortland$8K
- Jamie PiacentiniScarborough$6K
- Rosemary PainePortland$6K
- Brea SwihartAugusta$5K
- Kristen Schroeder-CyrBrunswick$5K
- Liana KellyBrunswick$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.